ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ivermectin for Human Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-2P11712
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Ivermectin for Human Market Research Report 2022
BUY CHAPTERS

Global Ivermectin for Human Market Research Report 2025

Code: QYRE-Auto-2P11712
Report
July 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Perrigo Company plc
Arbor Pharms LLC.
Taro
Teva Pharms USA
Wellona Pharma
Edenbridge Pharms
Galderma Laboratories LP

Ivermectin for Human Market Size

The global market for Ivermectin for Human was valued at US$ 67.1 million in the year 2024 and is projected to reach a revised size of US$ 85.7 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Ivermectin for Human Market

Ivermectin for Human Market

Ivermectin is an antiparasitic medication primarily used in veterinary medicine to treat various parasitic infections in animals. It has also been approved for human use in certain circumstances, such as the treatment of specific parasitic infections like onchocerciasis (river blindness) and strongyloidiasis.
North American market for Ivermectin for Human is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Ivermectin for Human is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Ivermectin for Human include Merck, Perrigo Company plc, Arbor Pharms LLC, TARO, Edenbridge Pharms, TEVA Pharms USA, Wellona Pharma, Galderma Laboratories LP, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ivermectin for Human, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ivermectin for Human.
The Ivermectin for Human market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ivermectin for Human market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ivermectin for Human manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Ivermectin for Human Market Report

Report Metric Details
Report Name Ivermectin for Human Market
Accounted market size in year US$ 67.1 million
Forecasted market size in 2031 US$ 85.7 million
CAGR 3.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Perrigo Company plc, Arbor Pharms LLC, TARO, Edenbridge Pharms, TEVA Pharms USA, Wellona Pharma, Galderma Laboratories LP
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Ivermectin for Human manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Ivermectin for Human in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Ivermectin for Human Market growing?

Ans: The Ivermectin for Human Market witnessing a CAGR of 3.6% during the forecast period 2025-2031.

What is the Ivermectin for Human Market size in 2031?

Ans: The Ivermectin for Human Market size in 2031 will be US$ 85.7 million.

Who are the main players in the Ivermectin for Human Market report?

Ans: The main players in the Ivermectin for Human Market are Merck, Perrigo Company plc, Arbor Pharms LLC, TARO, Edenbridge Pharms, TEVA Pharms USA, Wellona Pharma, Galderma Laboratories LP

What are the Application segmentation covered in the Ivermectin for Human Market report?

Ans: The Applications covered in the Ivermectin for Human Market report are For Onchocerciasis Treatment, For Headlice Treatment, Others

What are the Type segmentation covered in the Ivermectin for Human Market report?

Ans: The Types covered in the Ivermectin for Human Market report are Topical (Cream and Lotion), Oral, Injection

Recommended Reports

Antiparasitic Drugs

Animal Health Solutions

Infection & Therapy Markets

1 Ivermectin for Human Market Overview
1.1 Product Definition
1.2 Ivermectin for Human by Type
1.2.1 Global Ivermectin for Human Market Value Comparison by Type (2024 VS 2031)
1.2.2 Topical (Cream and Lotion)
1.2.3 Oral
1.2.4 Injection
1.3 Ivermectin for Human by Application
1.3.1 Global Ivermectin for Human Market Value by Application (2024 VS 2031)
1.3.2 For Onchocerciasis Treatment
1.3.3 For Headlice Treatment
1.3.4 Others
1.4 Global Ivermectin for Human Market Size Estimates and Forecasts
1.4.1 Global Ivermectin for Human Revenue 2020-2031
1.4.2 Global Ivermectin for Human Sales 2020-2031
1.4.3 Global Ivermectin for Human Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Ivermectin for Human Market Competition by Manufacturers
2.1 Global Ivermectin for Human Sales Market Share by Manufacturers (2020-2025)
2.2 Global Ivermectin for Human Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Ivermectin for Human Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Ivermectin for Human, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ivermectin for Human, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ivermectin for Human, Product Type & Application
2.7 Global Key Manufacturers of Ivermectin for Human, Date of Enter into This Industry
2.8 Global Ivermectin for Human Market Competitive Situation and Trends
2.8.1 Global Ivermectin for Human Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Ivermectin for Human Players Market Share by Revenue
2.8.3 Global Ivermectin for Human Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ivermectin for Human Market Scenario by Region
3.1 Global Ivermectin for Human Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Ivermectin for Human Sales by Region: 2020-2031
3.2.1 Global Ivermectin for Human Sales by Region: 2020-2025
3.2.2 Global Ivermectin for Human Sales by Region: 2026-2031
3.3 Global Ivermectin for Human Revenue by Region: 2020-2031
3.3.1 Global Ivermectin for Human Revenue by Region: 2020-2025
3.3.2 Global Ivermectin for Human Revenue by Region: 2026-2031
3.4 North America Ivermectin for Human Market Facts & Figures by Country
3.4.1 North America Ivermectin for Human Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Ivermectin for Human Sales by Country (2020-2031)
3.4.3 North America Ivermectin for Human Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ivermectin for Human Market Facts & Figures by Country
3.5.1 Europe Ivermectin for Human Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Ivermectin for Human Sales by Country (2020-2031)
3.5.3 Europe Ivermectin for Human Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ivermectin for Human Market Facts & Figures by Region
3.6.1 Asia Pacific Ivermectin for Human Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Ivermectin for Human Sales by Region (2020-2031)
3.6.3 Asia Pacific Ivermectin for Human Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Ivermectin for Human Market Facts & Figures by Country
3.7.1 Latin America Ivermectin for Human Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Ivermectin for Human Sales by Country (2020-2031)
3.7.3 Latin America Ivermectin for Human Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ivermectin for Human Market Facts & Figures by Country
3.8.1 Middle East and Africa Ivermectin for Human Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Ivermectin for Human Sales by Country (2020-2031)
3.8.3 Middle East and Africa Ivermectin for Human Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ivermectin for Human Sales by Type (2020-2031)
4.1.1 Global Ivermectin for Human Sales by Type (2020-2025)
4.1.2 Global Ivermectin for Human Sales by Type (2026-2031)
4.1.3 Global Ivermectin for Human Sales Market Share by Type (2020-2031)
4.2 Global Ivermectin for Human Revenue by Type (2020-2031)
4.2.1 Global Ivermectin for Human Revenue by Type (2020-2025)
4.2.2 Global Ivermectin for Human Revenue by Type (2026-2031)
4.2.3 Global Ivermectin for Human Revenue Market Share by Type (2020-2031)
4.3 Global Ivermectin for Human Price by Type (2020-2031)
5 Segment by Application
5.1 Global Ivermectin for Human Sales by Application (2020-2031)
5.1.1 Global Ivermectin for Human Sales by Application (2020-2025)
5.1.2 Global Ivermectin for Human Sales by Application (2026-2031)
5.1.3 Global Ivermectin for Human Sales Market Share by Application (2020-2031)
5.2 Global Ivermectin for Human Revenue by Application (2020-2031)
5.2.1 Global Ivermectin for Human Revenue by Application (2020-2025)
5.2.2 Global Ivermectin for Human Revenue by Application (2026-2031)
5.2.3 Global Ivermectin for Human Revenue Market Share by Application (2020-2031)
5.3 Global Ivermectin for Human Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Ivermectin for Human Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Ivermectin for Human Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Perrigo Company plc
6.2.1 Perrigo Company plc Company Information
6.2.2 Perrigo Company plc Description and Business Overview
6.2.3 Perrigo Company plc Ivermectin for Human Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Perrigo Company plc Ivermectin for Human Product Portfolio
6.2.5 Perrigo Company plc Recent Developments/Updates
6.3 Arbor Pharms LLC
6.3.1 Arbor Pharms LLC Company Information
6.3.2 Arbor Pharms LLC Description and Business Overview
6.3.3 Arbor Pharms LLC Ivermectin for Human Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Arbor Pharms LLC Ivermectin for Human Product Portfolio
6.3.5 Arbor Pharms LLC Recent Developments/Updates
6.4 TARO
6.4.1 TARO Company Information
6.4.2 TARO Description and Business Overview
6.4.3 TARO Ivermectin for Human Sales, Revenue and Gross Margin (2020-2025)
6.4.4 TARO Ivermectin for Human Product Portfolio
6.4.5 TARO Recent Developments/Updates
6.5 Edenbridge Pharms
6.5.1 Edenbridge Pharms Company Information
6.5.2 Edenbridge Pharms Description and Business Overview
6.5.3 Edenbridge Pharms Ivermectin for Human Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Edenbridge Pharms Ivermectin for Human Product Portfolio
6.5.5 Edenbridge Pharms Recent Developments/Updates
6.6 TEVA Pharms USA
6.6.1 TEVA Pharms USA Company Information
6.6.2 TEVA Pharms USA Description and Business Overview
6.6.3 TEVA Pharms USA Ivermectin for Human Sales, Revenue and Gross Margin (2020-2025)
6.6.4 TEVA Pharms USA Ivermectin for Human Product Portfolio
6.6.5 TEVA Pharms USA Recent Developments/Updates
6.7 Wellona Pharma
6.7.1 Wellona Pharma Company Information
6.7.2 Wellona Pharma Description and Business Overview
6.7.3 Wellona Pharma Ivermectin for Human Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Wellona Pharma Ivermectin for Human Product Portfolio
6.7.5 Wellona Pharma Recent Developments/Updates
6.8 Galderma Laboratories LP
6.8.1 Galderma Laboratories LP Company Information
6.8.2 Galderma Laboratories LP Description and Business Overview
6.8.3 Galderma Laboratories LP Ivermectin for Human Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Galderma Laboratories LP Ivermectin for Human Product Portfolio
6.8.5 Galderma Laboratories LP Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ivermectin for Human Industry Chain Analysis
7.2 Ivermectin for Human Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ivermectin for Human Production Mode & Process Analysis
7.4 Ivermectin for Human Sales and Marketing
7.4.1 Ivermectin for Human Sales Channels
7.4.2 Ivermectin for Human Distributors
7.5 Ivermectin for Human Customer Analysis
8 Ivermectin for Human Market Dynamics
8.1 Ivermectin for Human Industry Trends
8.2 Ivermectin for Human Market Drivers
8.3 Ivermectin for Human Market Challenges
8.4 Ivermectin for Human Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
Perrigo Company plc
Arbor Pharms LLC.
Taro
Teva Pharms USA
Wellona Pharma
Edenbridge Pharms
Galderma Laboratories LP
List of Tables
 Table 1. Global Ivermectin for Human Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Ivermectin for Human Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Ivermectin for Human Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Ivermectin for Human Sales (KG) of Key Manufacturers (2020-2025)
 Table 5. Global Ivermectin for Human Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Ivermectin for Human Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Ivermectin for Human Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Ivermectin for Human Average Price (USD/g) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Ivermectin for Human, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Ivermectin for Human, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Ivermectin for Human, Product Type & Application
 Table 12. Global Key Manufacturers of Ivermectin for Human, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Ivermectin for Human by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ivermectin for Human as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ivermectin for Human Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Ivermectin for Human Sales by Region (2020-2025) & (KG)
 Table 18. Global Ivermectin for Human Sales Market Share by Region (2020-2025)
 Table 19. Global Ivermectin for Human Sales by Region (2026-2031) & (KG)
 Table 20. Global Ivermectin for Human Sales Market Share by Region (2026-2031)
 Table 21. Global Ivermectin for Human Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Ivermectin for Human Revenue Market Share by Region (2020-2025)
 Table 23. Global Ivermectin for Human Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Ivermectin for Human Revenue Market Share by Region (2026-2031)
 Table 25. North America Ivermectin for Human Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Ivermectin for Human Sales by Country (2020-2025) & (KG)
 Table 27. North America Ivermectin for Human Sales by Country (2026-2031) & (KG)
 Table 28. North America Ivermectin for Human Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Ivermectin for Human Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Ivermectin for Human Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Ivermectin for Human Sales by Country (2020-2025) & (KG)
 Table 32. Europe Ivermectin for Human Sales by Country (2026-2031) & (KG)
 Table 33. Europe Ivermectin for Human Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Ivermectin for Human Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Ivermectin for Human Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Ivermectin for Human Sales by Region (2020-2025) & (KG)
 Table 37. Asia Pacific Ivermectin for Human Sales by Region (2026-2031) & (KG)
 Table 38. Asia Pacific Ivermectin for Human Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Ivermectin for Human Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Ivermectin for Human Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Ivermectin for Human Sales by Country (2020-2025) & (KG)
 Table 42. Latin America Ivermectin for Human Sales by Country (2026-2031) & (KG)
 Table 43. Latin America Ivermectin for Human Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Ivermectin for Human Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Ivermectin for Human Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Ivermectin for Human Sales by Country (2020-2025) & (KG)
 Table 47. Middle East and Africa Ivermectin for Human Sales by Country (2026-2031) & (KG)
 Table 48. Middle East and Africa Ivermectin for Human Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Ivermectin for Human Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Ivermectin for Human Sales (KG) by Type (2020-2025)
 Table 51. Global Ivermectin for Human Sales (KG) by Type (2026-2031)
 Table 52. Global Ivermectin for Human Sales Market Share by Type (2020-2025)
 Table 53. Global Ivermectin for Human Sales Market Share by Type (2026-2031)
 Table 54. Global Ivermectin for Human Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Ivermectin for Human Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Ivermectin for Human Revenue Market Share by Type (2020-2025)
 Table 57. Global Ivermectin for Human Revenue Market Share by Type (2026-2031)
 Table 58. Global Ivermectin for Human Price (USD/g) by Type (2020-2025)
 Table 59. Global Ivermectin for Human Price (USD/g) by Type (2026-2031)
 Table 60. Global Ivermectin for Human Sales (KG) by Application (2020-2025)
 Table 61. Global Ivermectin for Human Sales (KG) by Application (2026-2031)
 Table 62. Global Ivermectin for Human Sales Market Share by Application (2020-2025)
 Table 63. Global Ivermectin for Human Sales Market Share by Application (2026-2031)
 Table 64. Global Ivermectin for Human Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Ivermectin for Human Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Ivermectin for Human Revenue Market Share by Application (2020-2025)
 Table 67. Global Ivermectin for Human Revenue Market Share by Application (2026-2031)
 Table 68. Global Ivermectin for Human Price (USD/g) by Application (2020-2025)
 Table 69. Global Ivermectin for Human Price (USD/g) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Ivermectin for Human Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 73. Merck Ivermectin for Human Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Perrigo Company plc Company Information
 Table 76. Perrigo Company plc Description and Business Overview
 Table 77. Perrigo Company plc Ivermectin for Human Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 78. Perrigo Company plc Ivermectin for Human Product
 Table 79. Perrigo Company plc Recent Developments/Updates
 Table 80. Arbor Pharms LLC Company Information
 Table 81. Arbor Pharms LLC Description and Business Overview
 Table 82. Arbor Pharms LLC Ivermectin for Human Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 83. Arbor Pharms LLC Ivermectin for Human Product
 Table 84. Arbor Pharms LLC Recent Developments/Updates
 Table 85. TARO Company Information
 Table 86. TARO Description and Business Overview
 Table 87. TARO Ivermectin for Human Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 88. TARO Ivermectin for Human Product
 Table 89. TARO Recent Developments/Updates
 Table 90. Edenbridge Pharms Company Information
 Table 91. Edenbridge Pharms Description and Business Overview
 Table 92. Edenbridge Pharms Ivermectin for Human Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 93. Edenbridge Pharms Ivermectin for Human Product
 Table 94. Edenbridge Pharms Recent Developments/Updates
 Table 95. TEVA Pharms USA Company Information
 Table 96. TEVA Pharms USA Description and Business Overview
 Table 97. TEVA Pharms USA Ivermectin for Human Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 98. TEVA Pharms USA Ivermectin for Human Product
 Table 99. TEVA Pharms USA Recent Developments/Updates
 Table 100. Wellona Pharma Company Information
 Table 101. Wellona Pharma Description and Business Overview
 Table 102. Wellona Pharma Ivermectin for Human Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 103. Wellona Pharma Ivermectin for Human Product
 Table 104. Wellona Pharma Recent Developments/Updates
 Table 105. Galderma Laboratories LP Company Information
 Table 106. Galderma Laboratories LP Description and Business Overview
 Table 107. Galderma Laboratories LP Ivermectin for Human Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 108. Galderma Laboratories LP Ivermectin for Human Product
 Table 109. Galderma Laboratories LP Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Ivermectin for Human Distributors List
 Table 113. Ivermectin for Human Customers List
 Table 114. Ivermectin for Human Market Trends
 Table 115. Ivermectin for Human Market Drivers
 Table 116. Ivermectin for Human Market Challenges
 Table 117. Ivermectin for Human Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ivermectin for Human
 Figure 2. Global Ivermectin for Human Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Ivermectin for Human Market Share by Type: 2024 & 2031
 Figure 4. Topical (Cream and Lotion) Product Picture
 Figure 5. Oral Product Picture
 Figure 6. Injection Product Picture
 Figure 7. Global Ivermectin for Human Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Ivermectin for Human Market Share by Application: 2024 & 2031
 Figure 9. For Onchocerciasis Treatment
 Figure 10. For Headlice Treatment
 Figure 11. Others
 Figure 12. Global Ivermectin for Human Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Ivermectin for Human Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Ivermectin for Human Sales (2020-2031) & (KG)
 Figure 15. Global Ivermectin for Human Average Price (USD/g) & (2020-2031)
 Figure 16. Ivermectin for Human Report Years Considered
 Figure 17. Ivermectin for Human Sales Share by Manufacturers in 2024
 Figure 18. Global Ivermectin for Human Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Ivermectin for Human Players: Market Share by Revenue in Ivermectin for Human in 2024
 Figure 20. Ivermectin for Human Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Ivermectin for Human Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Ivermectin for Human Sales Market Share by Country (2020-2031)
 Figure 23. North America Ivermectin for Human Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Ivermectin for Human Sales Market Share by Country (2020-2031)
 Figure 27. Europe Ivermectin for Human Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Ivermectin for Human Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Ivermectin for Human Revenue Market Share by Region (2020-2031)
 Figure 35. China Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Ivermectin for Human Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Ivermectin for Human Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Ivermectin for Human Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Ivermectin for Human Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Ivermectin for Human Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Ivermectin for Human by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Ivermectin for Human by Type (2020-2031)
 Figure 56. Global Ivermectin for Human Price (USD/g) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Ivermectin for Human by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Ivermectin for Human by Application (2020-2031)
 Figure 59. Global Ivermectin for Human Price (USD/g) by Application (2020-2031)
 Figure 60. Ivermectin for Human Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Ivermectin in Veterinary Use Market Insights Forecast to 2030
Ivermectin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ivermectin Medication Market Insights Forecast to 2030
Parasiticides for Swine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Dewormer Market Insights Forecast to 2030
Global Animal Internal Dewormer Market Insights Forecast to 2030
Global Albendazole and Lvermectin Market Research Report 2024
Global Anthelmintics for Dogs and Cats Market Insights Forecast to 2030
Global Livestock Animal Parasiticides Market Insights Forecast to 2030
Global Livestock Internal Dewormer Market Insights Forecast to 2030
Global Livestock Dewormers Market Insights Forecast to 2030
Global Vermox Market Research Report 2024
Global Parasiticide for Animal Market Research Report 2024
Animal Parasiticide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Livestock Internal Parasiticide Market Insights Forecast to 2030
Global Companion Animal Parasiticides Market Insights Forecast to 2030
Global Farm Animal External Parasiticide Market Insights Forecast to 2030
Global Moxidectin API Market Research Report 2024
Global Farm Animal Internal Parasiticide Market Insights Forecast to 2030
Global In Vitro Deworming Medicine for Pets Market Research Report 2025

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions